# Hepatitis B (HBsAg) prevalence among obstetric patients in Caluquembe, Angola, 2023–2024

**Authors:** Anna E. Eberwein, Priscila Ribeiro Cummings, Daniel Cummings, Julia Andre, Kathryn H. Jacobsen

PMC · DOI: 10.1371/journal.pone.0327426 · PLOS One · 2025-07-03

## TL;DR

This study found a 4.7% hepatitis B prevalence among pregnant women in rural Angola, highlighting the need for better screening and education to prevent newborn infections.

## Contribution

The study provides new prevalence data and insights into knowledge gaps and healthcare worker recommendations for hepatitis B prevention in a rural Angolan setting.

## Key findings

- HBsAg prevalence among peripartum women was 4.7%.
- None of the HBsAg-positive women were previously aware of their status.
- Only one-third of women were familiar with hepatitis B or its vaccine.

## Abstract

Newborns who contract hepatitis B virus (HBV) infections at birth often develop chronic infections that can cause cirrhosis, liver cancer, and death in middle adulthood. Birth doses of hepatitis B vaccine can be lifesaving for babies born to mothers with hepatitis B infections. We aimed to measure hepatitis B prevalence among maternity patients in Huíla, a rural province in southwestern Angola.

We conducted a prospective case series study among 317 peripartum women at the Hospital Evangélico de Caluquembe from November 2023 to February 2024. Each participant received a point-of-care hepatitis B surface antigen (HBsAg) test and was asked about HBV and vaccine knowledge. We also conducted qualitative interviews about HBV prevention with 26 healthcare workers.

The HBsAg prevalence was 4.7%. None of the women who tested positive was previously aware of her status. Only about one-third of the women expressed familiarity with hepatitis B or HBV vaccines, and almost none reported that their older children had received HBV vaccines. Maternal health workers proposed hosting community meetings to provide education about HBV and birth-dose vaccination.

Only about half of Angolan babies are born at healthcare facilities, but more than 80% of women attend at least one antenatal care visit. Improved access to and uptake of hepatitis B screening at antenatal checkups is essential for ensuring that babies born to women with chronic hepatitis B infections are able to receive birth dose hepatitis B vaccines.

## Linked entities

- **Diseases:** hepatitis B (MONDO:0005344), cirrhosis (MONDO:0005155), liver cancer (MONDO:0002691)

## Full-text entities

- **Diseases:** chronic hepatitis B infections (MESH:D019694), cirrhosis (MESH:D005355), Hepatitis B (MESH:D006509), death (MESH:D003643), liver cancer (MESH:D006528)
- **Species:** Homo sapiens (human, species) [taxon 9606], Hepatitis B virus (no rank) [taxon 10407]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12225797/full.md

## References

18 references — full list in the complete paper: https://tomesphere.com/paper/PMC12225797/full.md

---
Source: https://tomesphere.com/paper/PMC12225797